<DOC>
	<DOCNO>NCT00252447</DOCNO>
	<brief_summary>Radical prostatectomy radical radiation therapy remain standard treatment approach patient clinically localized prostate cancer ( T1 , T2 ) .Radical prostatectomy effective disease organ confine time surgery . However , many series 60 % patient positive resection margin time surgery evidence suggest patient may curable surgery alone . A number preoperative clinical variable include clinical stage , serum Prostate Specific Antigen ( PSA ) Gleason scorea helpful determine probability find organ confine disease time syrgery .</brief_summary>
	<brief_title>Preop Conformal Radiotherapy - Prostate</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically confirm carcinoma prostate High risk localize disease define clinical T1 T2 plus [ ( ) Gleason ยกร7 , PSA &gt; 10 ng/ml &lt; 35 ng/ml OR ( ii ) PSA &gt; 15 ng/ml less &lt; 35 ng/ml ( Gleason ) ] No evidence pelvic lymph node metastasis CT scan within 4 month surgery No evidence distant metastases bone scan within 4 month surgery No contraindication pelvic radiation therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>